Trial Design Webinars

  1. Keeping Your Trials In Motion And Use AI Where It Makes Sense 2/2/2026

    Explore the "pinball" approach used by the Judi platform that is giving stakeholders a distinct competitive advantage in the clinical trial landscape.

  2. Embedding AI And Critical IRB Operations Data To Drive Intelligent Study Design 1/28/2026

    Explore how modern clinical trial design is being transformed by a rich array of data sources through this clear roadmap for navigating the evolving complexities of the industry.

  3. Yes, Your Study Is At Risk: Risk Mitigation Plans For Endpoints 1/15/2026

    Ocular endpoints often introduce unique bottlenecks that can stall enrollment and compromise data integrity. This presentation provides the tools for a streamlined, resilient clinical trial strategy.

  4. How To Use "Biotech Vision" 1/14/2026

    Aoife Brennan, CEO of Climb Bio, discusses how leveraging science and strategy brings you closer to a complete picture of your place in the industry.

  5. Meeting Patients Where They Are With Clinical Trials 1/13/2026

    Discover how to bridge gaps in patient diversity by fostering community trust and implementing inclusive research strategies.

  6. RTSM And IRT Solutions For Clinical Trials 12/10/2025

    Global leader in RTSM/IRT, helping sponsors and CROs speed study start-up, optimize supply, and manage complex trials with confidence.

  7. Early Phase Excellence: Navigating B Cell Therapies In Autoimmune Conditions 12/2/2025

    Watch as expert panelists share insights into the most critical considerations for navigating early-phase clinical development and designing studies that reliably translate mechanisms into meaningful patient outcomes.

  8. Obesity, From The Bench To The Bedside 12/2/2025

    Watch as experts in a multidisciplinary panel discuss the biological and clinical burden of obesity, emerging innovations in biotech and clinical practice, and patient experiences and societal factors.

  9. De-Risking Strategies For Schizophrenia Programs 11/18/2025

    Dr. Jeffrey Lieberman, Dr. Alan Kott, and Dr. Chris Murphy dissect why Phase 3 failures are increasing, how data quality issues cluster at specific sites, and why inadequate dose-response mapping continues to derail programs.

  10. Precision Feasibility And RWD Can Boost Participant Recruitment 11/17/2025

    Discover how integrating independent, holistic data with precision feasibility strategies can transform site enablement and patient recruitment to unlock new levels of trial success.